Showing of 16 results
Study validates the first-ever predictive AI biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer - Innovations in Cancer | Summer 2023
JAMA Study Finds Patients with Prostate Cancer Are Increasingly Choosing Active Surveillance Over Treatment
Active surveillance (AS) is increasingly recognized as the standard of care for low- and some favorable intermediate-risk prostate cancers (PC). - Innovations in Urology | Summer 2023
Cynthia Owusu, MD and Randy Vince, MD discuss how they help improve the social determinants of health and health disparities for African American men and women with prostate and breast cancers.
Daniel Spratt, MD discusses the obstacles of prostate cancer and shares breakthroughs and achievements.
Data support PSA screening, particularly in Black men, for whom there is a shortage of clinical trial evidence - Innovations in Urology | Summer 2022
Researchers Show Increased Survival Rate in Prostate Cancer Patients with Addition of Hormone Therapy Treatments
First-of-its-kind meta-analysis published in The Lancet Oncology - Innovations in Cancer Winter 2022
UH Seidman Cancer Center Using Machine Learning, Novel Statistical Methods to Identify Prostate Cancer Therapies
Urologic oncologist Jonathan Shoag, MD, finding new roles for old drugs - Innovations in Cancer | Fall 2021
Innovations in Urology | Fall 2021